OGT and breast carcinoma: In addition, Ac-5SGlcNAc, an OGT inhibitor that decreased global O-GlcNAcylation, but not N-glycosylation or N-glycosylation, suppresses the proliferation of pancreatic and breast cancer cells (54, 122, 132).